Background and activities

PhD, European Specialist in Clinical Chemistry and Laboratory Medicine, Clinical Chemist
 

Research area / work

  • Specialist at the Department of Medical Biochemistry, Helse Møre og Romsdal, Norway
  • Specialist in NOKLUS (Norwegian Organization for Quality Improvement of Laboratory Examinations)
  • Chair of Noklus' working group «Topic of the year-diabetes»
  • Lectures in Medical Biochemistry and Laboratory Quality Management

Scientific, academic and artistic work

A selection of recent journal publications, artistic productions, books, including book and report excerpts. See all publications in the database

Journal publications

  • Grimholt, Runa Marie; Fjeld, Bente; Selsås, Hilde; Schwettmann, Lutz; Klingenberg, Olav. (2019) Hb Aalesund (HBA2: c.400_406delAGCACCG), an Unstable α-Globin Variant Found in a Norwegian Patient Causing Moderate Hemolytic Anemia and Falsely High Hb A1c Using Ion Exchange High Performance Liquid Chromatography. Hemoglobin. vol. 43 (2).
  • Schwettmann, Lutz. (2016) Verifisering av referanseintervaller. Klinisk Biokemi i Norden. vol. 28 (1).
  • Schwettmann, Lutz; Berbu, Siw. (2015) Reference Interval and Status for Serum Folate and Serum Vitamin B12 in a Norwegian Population. Clinical Laboratory. vol. 61 (8).
  • Bolstad, Nils; Warren, David J.; Bjerner, Johan; Kravdal, Gunnhild; Schwettmann, Lutz; Olsen, Kari Hauge; Rustad, Pål; Nustad, Kjell Johannes. (2011) Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera. Clinical Chemistry and Laboratory Medicine. vol. 49 (12).
  • Schwettmann, Lutz; Rudowitz, Daniela; El Bendary, Omnia; Bahr, Matthias; Lichtinghagen, Ralf. (2011) Effect of overexpression of metalloproteinases on TIMP-1 and Procollagen IV gene Expression in murine liver. Experimental and Clinical Hepatology. vol. 7 (3-4).
  • Schwettmann, Lutz; Wehmeier, Michael; Jokovic, Dunja; Brand, Korbinian; Manns, Michael P.; Lichtinghagen, Ralf; Bahr, Matthias. (2008) Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases. Journal of Hepatology. vol. 49 (2).
  • Schwettmann, Lutz; Külpmann, Wolf Rüdiger; Vidal, Christian. (2006) Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study. Clinical Chemistry and Laboratory Medicine. vol. 44 (4).
  • Lichtinghagen, Ralf; Schwettmann, Lutz. (2004) Regulation und funktionelle Bedeutung von Matrixmetalloproteinasen und ihrer Inhibitoren in der Leber. Klinische Chemie Mitteilungen. vol. 35 (5).
  • Roemer, Andreas; Schwettmann, Lutz; Jung, M; Roigas, J; Kristiansen, G; Schorr, D; Loening, SA; Jung, Klaus; Lichtinghagen, Ralf. (2004) Increased mRNA expression of ADAMs in renal cell carcinoma and their association with clinical outcome. Oncology Reports. vol. 11 (2).
  • Roemer, Andreas; Schwettmann, Lutz; Jung, M; Stephan, C; Roigas, J; Kristiansen, G; Loening, SA; Lichtinghagen, Ralf; Jung, Klaus. (2004) The membrane proteases adams and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers?. Journal of Urology. vol. 172 (6).
  • Schwettmann, Lutz; Lichtinghagen, Ralf. (2002) ADAMS: Features and significance for the extracellular matrix. Klinische Chemie Mitteilungen. vol. 33.
  • Schwettmann, Lutz; Tschesche, Harald. (2001) Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin. Protein Expression and Purification. vol. 21 (1).